BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2126705)

  • 1. [Experimental criteria for interpretation of bacterial sensitivity to dioxidine determined by diffusion from the disks].
    Ponomareva TR; Malakhova VA
    Antibiot Khimioter; 1990 Jul; 35(7):23-5. PubMed ID: 2126705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sensitivity of clinical bacterial strains to dioxidine in vitro under aerobic and anaerobic conditions].
    Ponomareva TR
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):199-202. PubMed ID: 3579247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibacterial activity of dioxidine under aero- and anaerobic conditions].
    Bol'shakov LV
    Antibiot Med Biotekhnol; 1986 Oct; 31(10):760-4. PubMed ID: 3789685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and experimental study of dioxidine. Its antibacterial action].
    Bekbergenov BM; Antipov AV; Danil'iants EV; Korolev PN; Glezer GA
    Antibiotiki; 1982 May; 27(5):349-52. PubMed ID: 6179463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K; Uete T
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in sensitivity of clinical strains of bacteria to dioxidine from 1984 to 1988].
    Bol'shakov LV
    Antibiot Khimioter; 1990 Sep; 35(9):17-9. PubMed ID: 2275583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro antibacterial activity of apalcillin on aerobic bacteria and the regression curve].
    Soussy CJ; Duval J; Chanal M; Sirot D; Bergogne-Bérézin E; Joly-Guillou ML; Malbruny B; Morel C
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):660-4. PubMed ID: 3054743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacterial effects of niridazole. II. Effects on aerobic and anaerobic bacteria].
    Hof H; Müller KM
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):265-71. PubMed ID: 6299027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A microbiological test system for determining dioxidine levels in biological fluids].
    Ponomareva TR; Malakhova VA
    Antibiot Khimioter; 1989 Apr; 34(4):261-3. PubMed ID: 2665675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro studies of tobramycin sensitivity of bacterial strains isolated from children treated in the Institute for Mother and Child].
    Duroś H; Nowakowska K
    Probl Med Wieku Rozwoj; 1982; 11():117-20. PubMed ID: 6817325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity of bacteria to antibiotics. Evaluation of a rapid automatic method (author's transl)].
    Acar JF; Swift RL; McKie J; Quentin C
    Pathol Biol (Paris); 1978 Feb; 26(2):137-44. PubMed ID: 97613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aerobic activity of metronidazole against anaerobic bacteria.
    Dione N; Khelaifia S; Lagier JC; Raoult D
    Int J Antimicrob Agents; 2015 May; 45(5):537-40. PubMed ID: 25813393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical laboratory approach to estimating the effective administration dose of imipenem/cilastatin. Evaluation of the disk susceptibility test and its interpretation system].
    Matsuo K; Uete T
    Jpn J Antibiot; 1989 Nov; 42(11):2377-92. PubMed ID: 2621780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of various bacterial growth inhibitors as selective agents for isolation of soil Actinomyces].
    Terekhova LP; Galatenko OA; Alferova IV; Preobrazhenskaia TP
    Antibiot Khimioter; 1991 Oct; 36(10):5-8. PubMed ID: 1805699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical laboratory approach to evaluate administration dose of arbekacin. Reevaluation of in vitro MIC break points in the disk susceptibility test].
    Matsuo K; Uete T
    Jpn J Antibiot; 1994 Aug; 47(8):1041-52. PubMed ID: 7933533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Computerized analysis of activity profiles of beta-lactams].
    Pitton JS; Philippin JL; Fournier P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):581-5. PubMed ID: 3937131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimicrobial activity of new beta-lactams and aminoglycosides in vitro under conditions of anaerobiosis].
    Bol'shakov LV; Bogomolova NS; Shenderov BA
    Antibiot Khimioter; 1989 Jul; 34(7):534-9. PubMed ID: 2818086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple method for determining bacterial susceptibility to aminoglycosides.
    Hinchliffe PM; Robertson L; Farrell ID; Kirkwood BR
    J Med Microbiol; 1977 Aug; 10(3):381-7. PubMed ID: 408495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients.
    King P; Citron DM; Griffith DC; Lomovskaya O; Dudley MN
    Diagn Microbiol Infect Dis; 2010 Feb; 66(2):181-6. PubMed ID: 19828274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.